James Ziogas

Associate Professor James Ziogas holds a BSc (Hons) and PhD from the University of Melbourne and is a longstanding member of the Department of Biochemistry and Pharmacology in the School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne. With over 25 years of service, he received the University of Melbourne Service Recognition 25 Year Bronze award in 2020. Currently serving as Deputy Head of the Department of Biochemistry and Pharmacology and Program Director for the Bachelor of Biomedicine, Ziogas has played a key role in pharmacology education, including leading efforts to ensure quality graduates in pharmacology and evaluating pharmacology curricula across Australian science and health-related degree programs. His involvement extends to the Australian Venom Research Unit and the Centre for Free Radical Chemistry and Biotechnology.

James Ziogas's primary research interest is receptor pharmacology, encompassing areas such as drug metabolism using high-resolution mass spectrometry techniques like HiTIME for nontargeted detection of metabolites and stable isotope labelling, cardioprotection mechanisms, vasoconstriction via calcium channels and endothelin, ischemia-reperfusion injury, synthetic opioids residue analysis from drug paraphernalia, purinergic transmission, and neuroeffector interactions. He has authored 66 publications garnering over 1,700 citations. Notable publications include 'An evaluation of pharmacology curricula in Australian science and health-related degree programs' (2013), 'High-Resolution Twin-Ion Metabolite Extraction (HiTIME) Mass Spectrometry: Nontargeted Detection of Unknown Drug Metabolites' (2015), 'Aliskiren Reduces Myocardial Ischemia-Reperfusion Injury by a Bradykinin B2 Receptor- and Angiotensin AT2 Receptor-Mediated Mechanism' (2014), 'Trace Residue Identification, Characterization and Longitudinal Monitoring of the Novel Synthetic Opioid β-U10' (2022), and 'Using high-resolution Twin-Ion Metabolite Extraction (HiTIME) mass spectrometry with stable isotope labelling to investigate the metabolism of valproic acid in vivo' (2019). Ziogas contributes to clinical proteomics and interdisciplinary research teams advancing biomedical science.

Professional Email: jamesz@unimelb.edu.au